|
MAD2L1BP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.921600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.902060E-02 |
| Normal-vs-Stage2 |
8.957000E-01 |
| Normal-vs-Stage3 |
8.670100E-02 |
| Normal-vs-Stage4 |
2.302000E-02 |
| Stage1-vs-Stage2 |
1.813380E-01 |
| Stage1-vs-Stage3 |
1.644870E-03 |
| Stage1-vs-Stage4 |
1.565060E-04 |
| Stage2-vs-Stage3 |
3.526200E-01 |
| Stage2-vs-Stage4 |
2.276400E-01 |
| Stage3-vs-Stage4 |
6.532200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.463600E-01 |
| Normal-vs-AfricanAmerican |
1.452250E-01 |
| Normal-vs-Asian |
5.460600E-01 |
| Caucasian-vs-AfricanAmerican |
1.141450E-01 |
| Caucasian-vs-Asian |
8.402000E-01 |
| AfricanAmerican-vs-Asian |
1.485420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.531000E-01 |
| Normal-vs-Female |
2.412200E-02 |
| Male-vs-Female |
4.063500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.484000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.881800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.357400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.257200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.485800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.910200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.722200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.502600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.052400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.558200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.586440E-02 |
| Normal-vs-Grade 2 |
6.912300E-02 |
| Normal-vs-Grade 3 |
9.237600E-01 |
| Normal-vs-Grade 4 |
1.78660000005326E-06 |
| Grade 1-vs-Grade 2 |
1.610150E-01 |
| Grade 1-vs-Grade 3 |
2.385600E-02 |
| Grade 1-vs-Grade 4 |
1.66229999999379E-05 |
| Grade 2-vs-Grade 3 |
2.321800E-01 |
| Grade 2-vs-Grade 4 |
5.41400002607162E-09 |
| Grade 3-vs-Grade 4 |
1.399460E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.036600E-04 |
| Normal-vs-ccB subtype |
1.227440E-01 |
| ccA subtype-vs-ccB subtype |
2.044700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.023800E-01 |
| Normal-vs-N1 |
1.585780E-01 |
| N0-vs-N1 |
2.176200E-01 |
|
|
